OvaScience Inc. (Nasdaq: OVAS) does not expect to meet its 2015 goal of 1,000 AUGMENT treatment cycles. The stock price plummeted $5.95 to close at $8.57.
OvaScience will not meet goal
September 29, 2015 at 17:50 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|